# Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19

> **NCT04384380** · NA · COMPLETED · sponsor: **Taoyuan General Hospital** · enrollment: 33 (actual)

## Conditions studied

- Coronavirus Infection

## Interventions

- **DRUG:** Hydroxychloroquine Sulfate 200 MG [Plaquenil]

## Key facts

- **NCT ID:** NCT04384380
- **Lead sponsor:** Taoyuan General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-05-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04384380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04384380, "Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04384380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*